As of January 23, 2025, Eyenovia (EYEN) has a market cap of $6.184 million USD. According to our data, Eyenovia is ranked No.8995 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $6.18 M |
-61.99%
|
Dec 31, 2024 | $16.27 M |
-92.98%
|
Dec 29, 2023 | $0.23 B |
27.61%
|
Dec 30, 2022 | $0.18 B |
-59.25%
|
Dec 31, 2021 | $0.45 B |
-33.99%
|
Dec 31, 2020 | $0.68 B |
35.27%
|
Dec 31, 2019 | $0.50 B |
57.19%
|
Dec 31, 2018 | $0.32 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alcon
ALC
|
$43.91 B |
-0.001 M
|
Switzerland
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Cooper Companies
COO
|
$19.00 B |
-0.001 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Santen Pharmaceutical
4536.T
|
$3.40 B |
-0.000 M
|
Japan
|
Hoya
7741.T
|
$47.61 B |
11.068 M
|
Japan
|
EssilorLuxottica
EL.PA
|
$120.50 B |
0.000 M
|
France
|
Glaukos
GKOS
|
$8.83 B |
0.000 M
|
USA
|
Kala Pharmaceuticals
KALA
|
$36.53 M |
0.000 M
|
USA
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
Market Cap | = | EYEN Stock Price | * | EYEN Shares Outstanding |
= | $0.06 | * | 0.11 B | |
= | $6.18 M |